SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-138283
Filing Date
2020-05-11
Accepted
2020-05-11 07:46:57
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d830975ds3.htm S-3 273615
2 EX-1.2 d830975dex12.htm EX-1.2 202068
3 EX-5.1 d830975dex51.htm EX-5.1 20289
4 EX-23.1 d830975dex231.htm EX-23.1 2311
5 GRAPHIC g830975ex51g1.jpg GRAPHIC 4109
6 GRAPHIC g830975ex51g2.jpg GRAPHIC 1586
7 GRAPHIC g830975g0506073032319.jpg GRAPHIC 3445
  Complete submission text file 0001193125-20-138283.txt   512444
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238151 | Film No.: 20862647
SIC: 2834 Pharmaceutical Preparations